Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Eastman Kodak Company    

EASTMAN KODAK COMPANY
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

WSJ BLOG/Health: A.M. Vitals: FDA Adds a Warning, Removes Another From Statin Labels

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/29/2012 | 03:13pm CEST

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Katherine Hobson

The FDA and Statins: The FDA will require drug makers to add to statin labels a warning about a small increase in the risk of increased blood-sugar levels and of diabetes linked to the drugs, the WSJ reports. The labels will also include the information that some patients have experienced an adverse reaction of memory loss and confusion, though that won't be a full-fledged warning. But the FDA also removed a warning about the need for liver-enzyme monitoring from statin labels. Cardiologists tell the paper that most people should keep taking their statins despite the new label information.

Benefit Cuts at Kodak: Eastman Kodak is proposing to end health-care benefits for about 16,000 Medicare-eligible retirees in order to save about $20.5 million annually, the Associated Press reports. Kodak filed for Chapter 11 last month.

Insurer and Physicians' Group Clash: Insurer Blue Shield of California filed a demand for at least $10.5 million in damages from Monarch HealthCare, a physician association that sold its management arm to a unit of UnitedHealth Group, the WSJ reports. Blue Shield alleges that Monarch tried to direct Blue Shield members into competing health plans and that physicians stopped seeing some members, violating the contract between Blue Shield and Monarch. Monarch says it objects to "the mischaracterizations made by Blue Shield," the paper says. The case was submitted for binding arbitration.

The Right Dose of Selenium: A review of previously published research appearing in the Lancet suggests that large doses of selenium supplements could raise the risk for type 2 diabetes, Bloomberg News reports. The author of the review suggests that people with blood selenium levels of 122 micrograms per liter or higher shouldn't supplement with the mineral, which has been associated with a lower risk of some cancers, BN says.

Image: iStockphoto

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

Stocks mentioned in the article : Eastman Kodak Company
Stocks mentioned in the article
ChangeLast1st jan.
UNITEDHEALTH GROUP -0.38% 244.26 Delayed Quote.12.45%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EASTMAN KODAK COMPANY
05/19EASTMAN KODAK : Little known details of famous people
AQ
05/10EASTMAN KODAK : Management's Discussion and Analysis of Financial Condition and ..
AQ
05/09EASTMAN KODAK CO : Results of Operations and Financial Condition, Financial Stat..
AQ
05/09EASTMAN KODAK : Kodak Reports First-Quarter 2018 Financial Results
BU
05/03EASTMAN KODAK : Blockchain Technology to Become More Popular in Banking and Fina..
PR
05/02EASTMAN KODAK : Kodak to Report First-Quarter 2018 Financial Results on May 9, 2..
BU
04/25EASTMAN KODAK COMPANY : Today's Research Reports on Trending Tickers: Eastman Ko..
AC
04/19EASTMAN KODAK : An Application for the Trademark "EASTMAN" Has Been Filed by Eas..
AQ
04/09EASTMAN KODAK CO : Change in Directors or Principal Officers, Financial Statemen..
AQ
04/09KODAK : Announces John O’Grady as New President of Print Systems Division
BU
More news
Income Statement Evolution
Managers
NameTitle
Jeff J. Clarke Chief Executive Officer & Director
James V. Continenza Chairman
David Bullwinkle Chief Financial Officer & Senior Vice President
Kim E. VanGelder Chief Information Officer & Senior Vice President
Terry R. Taber Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EASTMAN KODAK COMPANY252
LARGAN PRECISION CO., LTD.--.--%17 562
Q TECHNOLOGY (GROUP) CO LTD-38.40%988
GOPRO INC-27.87%810
VITEC GROUP PLC3.54%727
COWELL E HOLDINGS INC-30.30%195